1.8 Bimeda: Altresyn® (altrenogest) Rebranded OvaMedTM Following Product Acquisition from Ceva Animal Health
Oakbrook Terrace, Ill.; March 1st, 2017 – Bimeda Inc. is pleased to announce the renaming of its altrenogest product for horses.
The product, formerly marketed as Altresyn® was recently acquired from Ceva Animal Health as part of Bimeda’s strategic expansion into the equine segment.
“The trade name OvaMedTM more closely aligns with Bimeda’s brand identity and is a key step in the integration of the recently-acquired equine products within our portfolio and global brand” said Emmanuelle Lemaire-Galliot, Marketing Manager for Bimeda North America.
OvaMedTM is currently shipping to Bimeda’s distributors to fulfill veterinary orders. For more information, visit www.bimedaus.com and www.bimedaequine.com